StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CLVTCLARIVATE PLC
stockpulse.co.kr
NYSE
$1.86▼ 0.80%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.19BShares out 6.400M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

18
  • 10.13After-hours26.10.14 05:25
    8-K/AKey event#●●●

    CLARIVATE PLC

    Clarivate completed the sale of its Life Sciences and Healthcare (LS&H) business on October 6, 2026, for an aggregate purchase price of $600 million. The company received approximately $488.4 million in cash at closing, with the remainder consisting of a $75 million unsecured senior note and $25 million in deferred cash. Proceeds from the sale were used to partially redeem Senior Secured Notes due 2028 and Senior Notes due 2029.…more

    $1.86-0.80%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.8After-hours26.10.09 05:41
    4Ownership

    CLARIVATE PLC

    Clarivate PLC insider Henry Levy reported a change in beneficial ownership of company securities on October 6, 2026. This filing serves as the official Form 4 disclosure of the insider's equity transaction to the SEC.…more

    $1.86-0.80%vs prev close
    View filingShare
  • 10.6After-hours26.10.07 05:29
    8-KKey event

    CLARIVATE PLC

    Clarivate Plc completed the $600 million sale of its Life Sciences and Healthcare business to Altaris, LLC on October 6, 2026. The transaction includes $500 million in cash, a $75 million unsecured senior note, and $25 million in deferred consideration, which the company intends to use to reduce debt and strengthen its balance sheet. Clarivate is now focusing on its Academia & Government and Intellectual Property segments and will update its 2026 full-year guidance during its third-quarter earnings release on November 3, 2026.…more

    $1.86-0.80%vs prev close
    View filingShare

17 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.17Pre-market26.09.17 21:18
    #●●●

    Clarivate Announces $75M Cash Tender Offer for 2028 Senior Secured Notes…more

    Clarivate Science Holdings has announced a cash tender offer to repurchase up to $75 million of its 3.875% senior secured notes due 2028. The offer is set to expire on September 23, with settlement expected on September 25.…more

    $1.86-0.80%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga